New depression pill shows promise in Drug-Resistant patients
Symptom relief
Completed
This study tested an experimental daily pill called MAP4343 in 126 adults whose depression did not improve with standard antidepressants. Participants took the drug or a placebo for 6 weeks, and researchers measured changes in depression symptoms using a standard rating scale. Th…
Phase: PHASE2 • Sponsor: Mapreg • Aim: Symptom relief
Last updated May 08, 2026 12:02 UTC